J&J Warns of $400M Tariff Blow, Medtech Supply Chains in Focus
April 19, 2025
Johnson & Johnson has warned of a $400 million tariff cost in 2025, largely driven by China-related levies. The financial hit is expected to weigh
Johnson & Johnson has warned of a $400 million tariff cost in 2025, largely driven by China-related levies. The financial hit is expected to weigh
Despite political pressure and proposed tax incentives, most U.S. supply chain leaders see reshoring as too costly, with many warning tariffs could tip the economy
How Cross-Functional Agility Powers a More Resilient Manufacturing Model This is Part 3 of Aligning Factory and Supply Chain, our editorial series for senior operations
New research shows emissions from AI chip manufacturing have surged 357% in a year, exposing a lesser-known environmental cost of the AI boom—and a growing
A new national security probe into pharmaceutical imports could lead to sweeping tariffs, threatening cost increases across global supply chains and reshoring challenges for manufacturers.
As new tariff rules kick in, procurement leaders face a surge in documentation requirements—raising operational risk and exposing a critical weak spot in compliance workflows.
This is Part 2 of Aligning Factory and Supply Chain, our special series for supply chain and operations leaders working to close the gap between
Pharmaceuticals could soon join the growing list of goods facing U.S. tariffs, with President Trump signaling a clampdown aimed at boosting domestic drug manufacturing—though the
As President Trump halts reciprocal tariffs for 90 days to open trade talks with more than 75 countries, his administration has simultaneously escalated duties on
No longer just digital replicas, today’s digital twins are reshaping how supply chain and logistics leaders make decisions—from warehouse layout to fleet dispatch and network
Johnson & Johnson has warned of a $400 million tariff cost in 2025, largely driven by China-related levies. The financial hit is expected to weigh
Despite political pressure and proposed tax incentives, most U.S. supply chain leaders see reshoring as too costly, with many warning tariffs could tip the economy
How Cross-Functional Agility Powers a More Resilient Manufacturing Model This is Part 3 of Aligning Factory and Supply Chain, our editorial series for senior operations
New research shows emissions from AI chip manufacturing have surged 357% in a year, exposing a lesser-known environmental cost of the AI boom—and a growing
A new national security probe into pharmaceutical imports could lead to sweeping tariffs, threatening cost increases across global supply chains and reshoring challenges for manufacturers.
As new tariff rules kick in, procurement leaders face a surge in documentation requirements—raising operational risk and exposing a critical weak spot in compliance workflows.
This is Part 2 of Aligning Factory and Supply Chain, our special series for supply chain and operations leaders working to close the gap between
Pharmaceuticals could soon join the growing list of goods facing U.S. tariffs, with President Trump signaling a clampdown aimed at boosting domestic drug manufacturing—though the
As President Trump halts reciprocal tariffs for 90 days to open trade talks with more than 75 countries, his administration has simultaneously escalated duties on
No longer just digital replicas, today’s digital twins are reshaping how supply chain and logistics leaders make decisions—from warehouse layout to fleet dispatch and network